Industrial Affairs Committee (Iceland)

Valbiotis announces that it has received Food and Drug Administration (FDA) approval for New Dietary Ingredient (NDI) status

Retrieved on: 
Tuesday, December 12, 2023
NDI, Risk, Incidence, Executive Committee, Industrial Affairs Committee (Iceland), Dietary supplement, FDA, Letter, CEST, Regulatory News Service, US Foods, Food, Safety

La Rochelle, December 11, 2023 (08:00 p.m. CEST) – Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a commercially-oriented company specializing in dietary supplements, committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces that it has received approval from the Food and Drug Administration (FDA) for New Dietary Ingredient (NDI) status for a plant extract present in all its TOTUM products.

Key Points: 
  • La Rochelle, December 11, 2023 (08:00 p.m. CEST) – Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a commercially-oriented company specializing in dietary supplements, committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces that it has received approval from the Food and Drug Administration (FDA) for New Dietary Ingredient (NDI) status for a plant extract present in all its TOTUM products.
  • The US Food and Drug Administration (FDA) imposes specific requirements on manufacturers and distributors wishing to market dietary supplements containing "new dietary ingredients".
  • Sébastien PELTIER, CEO and co-founder, emphasizes: "Obtaining the New Dietary Ingredient (NDI) status for this plant extract is a gratifying milestone, albeit expected, marking the conclusion of a standard authorization process.
  • This comes at a time when the growing incidence of metabolic and cardiovascular diseases worldwide poses a public health challenge."

Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes

Retrieved on: 
Wednesday, November 8, 2023
INAF, Meal, Research, Trial of the century, Faculty, Fasting, Stomach, Peptide YY, Endocrine gland, Membrane protein, GIP, Human, Regulatory News Service, Université Laval, Hyperinsulinemia, Agonal respiration, PYY, Type 2 diabetes, Inflammation, Fibrinogen, Metabolism, Volunteering, Development, Glycated hemoglobin, Phase, Prediabetes, Food court, Lipid, Disease, Risk, Plant, Medicine, Research and development, Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Medical school, Industrial Affairs Committee (Iceland), Partnership, Sensation, Blood, Nutrition, Hormone, CET, Safety, Insulin resistance, Overweight, Gastric inhibitory polypeptide, Glucose, Insulin, Pharmaceutical industry, Dietary supplement, Medical device, Animal feed

Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes

Key Points: 
  • Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • The study confirms TOTUM•63's efficacy results, in particular the lasting reduction in glycated hemoglobin, one of the main markers of prediabetes and type 2 diabetes.
  • It demonstrates TOTUM•63's multi-target mode of action in subjects at risk, improving the efficacy of energy metabolism, particularly after meals.
  • Mode of action clinical results: TOTUM•63 regulates energy metabolism
    In addition to the positive clinical efficacy studies already conducted, the mode of action study was carried out on 19 overweight or obese volunteers at risk of developing type 2 diabetes.

Dairy Council of California Attends International Dairy Federation’s World Dairy Summit

Retrieved on: 
Wednesday, November 1, 2023
Health, Milk, Research, Dairy Council of California, International Dairy Agreement, Industrial Affairs Committee (Iceland), Farmer, Pregnancy, Hunger, Investment, Dairy

SACRAMENTO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Dairy Council of California is proud to announce its participation in the International Dairy Federation’s World Dairy Summit recently held in Chicago.

Key Points: 
  • SACRAMENTO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Dairy Council of California is proud to announce its participation in the International Dairy Federation’s World Dairy Summit recently held in Chicago.
  • As a leading advocate for dairy education and nutrition, Dairy Council of California joined the global dairy community in promoting the many benefits of dairy products while sharing insights on innovation for nutrition security.
  • The World Dairy Summit leadership welcomed attendees from over 50 countries from around the world to showcase dairy’s boundless potential and endless possibilities to nourish the world.
  • “The World Dairy Summit offered opportunities to meet global dairy leaders and educators and to share best practices and innovations.

Glo Fiber Announces Expansion of its Fiber Network to City of Lancaster, PA

Retrieved on: 
Wednesday, November 1, 2023
Wi-Fi, Data-rate units, Engineering, FTTH, Internet, Industrial Affairs Committee (Iceland), Partnership, Economic development, Shentel, Mid-Atlantic (United States), Cable television, Internet service provider, City

EDINBURG, Va., Nov. 1, 2023 /PRNewswire/ -- Glo Fiber, powered by Shenandoah Telecommunications Company ("Shentel") (Nasdaq: SHEN), announced they have reached an innovative partnership with municipal officials to deploy next generation fiber-to-the-home (FTTH) broadband services to the City of Lancaster, Pennsylvania. Glo Fiber will utilize portions of the City's extensive existing fiber network and provide key fiber assets to the City for Smart City uses. Engineering work is currently underway, and construction is slated to begin mid-2024 and last approximately 18 months.

Key Points: 
  • Glo Fiber will utilize portions of the City's extensive existing fiber network and provide key fiber assets to the City for Smart City uses.
  • The fiber-to-the-home network, coupled with Shentel's 9,000-mile regional fiber network, enables Glo Fiber to deliver high speeds, low latency, and unparalleled reliability.
  • "The City of Lancaster has shown great foresight into the future of technology for their citizens, and Glo Fiber is thrilled to collaborate with them to bring complete broadband coverage in the City.
  • As a leading broadband internet provider in the Mid-Atlantic region, Glo Fiber takes great pride in several key differentiators compared to our competitors:

Organic Trade Association hails long-awaited organic animal welfare rule

Retrieved on: 
Wednesday, October 25, 2023
Organic Trade Association, Comment, Drinking, Mission, Charmaine Clamor, Sound, Ambiguity, Organic egg production, System, Cattle, Health, OTA, Government, Poultry, Farm, Livestock, Climate, U.S. Department of Agriculture Cotton Annex, Meat, Farmer, USDA, Food court, Research, Administration, Organic, NOT, Sunlight, National Organic Program, Chicken, Egg, Transport, Advocacy, Industrial Affairs Committee (Iceland), Organic Foods Production Act of 1990, Soil, Animal, U.S. Department of Labor, Office of Inspector General, Organic farming, Agriculture, Poultry farming

“The organic sector and organic consumers have been clamoring for stricter animal welfare standards for 20 years now, and the OTA and its members have spearheaded that fight,” said Tom Chapman, CEO of the Organic Trade Association.

Key Points: 
  • “The organic sector and organic consumers have been clamoring for stricter animal welfare standards for 20 years now, and the OTA and its members have spearheaded that fight,” said Tom Chapman, CEO of the Organic Trade Association.
  • “All organic poultry producers will need to provide real access to the outdoors and that is what certified organic represents.
  • We celebrate a final rule that will strengthen organic animal welfare standards, better align organic producers and certifiers, and meet consumer expectations for organic livestock products,” said Carolyn Gahn, Senior Director, Mission & Advocacy for Applegate Farms.
  • USDA, through its National Organic Program, sets the federal standards for all organic products certified to the USDA Organic label.

Covenant Logistics Honored with the 2023 ATA Diversity Equity and Inclusion Change Leader Award

Retrieved on: 
Tuesday, October 24, 2023
ATA, Operation, American Trucking Associations, Conference, Inclusion, Covenant Logistics, Human resources, 3rd Marine Logistics Group, Industrial Affairs Committee (Iceland), Culture, Covenant, MCE, Empathy, Security (finance), Exhibition, Safety

CHATTANOOGA, Tenn., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. has been honored with the 2023 ATA Diversity Equity and Inclusion Change Leader Award.

Key Points: 
  • CHATTANOOGA, Tenn., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. has been honored with the 2023 ATA Diversity Equity and Inclusion Change Leader Award.
  • In an industry as dynamic and essential as trucking, the importance of diversity, equity, and inclusion cannot be overstated.
  • Recognizing this, the American Trucking Association (ATA) celebrated eight remarkable companies with the 2023 ATA Diversity Equity and Inclusion Change Leader Award at this year’s ATA Management Conference and Exhibition (MCE).
  • To learn more about our Diversity, Equity, Inclusion, and Belonging initiatives, check out our latest Belonging at Covenant document here .

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes

Retrieved on: 
Monday, October 2, 2023
Volunteering, Communication, Partnership, American Diabetes Association, European Association for the Study of Diabetes, Research and development, Development, EASD, Regulatory News Service, Congress, Research, Prediabetes, Phase, ADA, Industrial Affairs Committee (Iceland), Pharmaceutical industry, Diabetes

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes

Key Points: 
  • VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • Valbiotis: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
    The Phase II/III clinical study REVERSE-IT, carried out with the active substance TOTUM•63, in partnership with Nestlé Health Science, will be presented on October 3, during an oral communication at the congress of the European Association for the Study of Diabetes (EASD) 2023.
  • This communication will detail the protocol of the REVERSE-IT study, against early glycemic disorders, as well as the complete characteristics of the population included (636 volunteers), at the beginning of the study.
  • “The success of the REVERSE-IT study constitutes a breakthrough for a non-drug approach to prediabetes and untreated early stages of type 2 diabetes.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Friday, September 1, 2023
Swiss Federal Institute of Technology, Swiss, Braunschweig, Scripps Research, Therapy, Biopharmaceutical, Ibete, Anticalin, CSO, Institute of technology, Biotechnology, Hansa, United States Air Force Scientific Advisory Board, Research, Science, Boehringer Ingelheim, Natural science, Executive Committee, Immunoglobulin G, Walter, Biology, Ghassan Hitto, Research fellow, Industrial Affairs Committee (Iceland), Technical University of Braunschweig, Swiss Federal Institute of Aquatic Science and Technology, Fine chemical, Sanofi

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Retrieved on: 
Friday, September 1, 2023
Swiss Federal Institute of Technology, Swiss, Braunschweig, Scripps Research, Therapy, Biopharmaceutical, Ibete, Anticalin, CSO, Institute of technology, Biotechnology, Hansa, United States Air Force Scientific Advisory Board, Research, Science, Boehringer Ingelheim, Natural science, Executive Committee, Immunoglobulin G, Walter, Biology, Ghassan Hitto, Research fellow, Industrial Affairs Committee (Iceland), Technical University of Braunschweig, Swiss Federal Institute of Aquatic Science and Technology, Fine chemical, Sanofi

LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.

Key Points: 
  • LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023.
  • Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019.
  • Søren Tulstrup, President and CEO, Hansa Biopharma said, "We are thrilled to welcome Hitto to Hansa at this pivotal time.
  • Dr. Hitto Kaufmann has served as Chief Scientific Officer at Pieris Pharmaceuticals since 2019.

Critical Infrastructure Cybersecurity Boosted by NEMA and ISA Partnership

Retrieved on: 
Thursday, June 29, 2023
International Society of Automation, International Electrotechnical Commission, National Electrical Manufacturers Association, Particular, Partnership, CRISP, Senior, NEMA, American National Standards Institute, Act, ANSI, ICS, Organization, Industrial Affairs Committee (Iceland), MOU, ISA, IEC, International Society, Technical, Automation, Medical device, Audit, Assurance services

OT and ICS enable the functionality of numerous manufacturing processes, especially in the production of critical infrastructure components.

Key Points: 
  • OT and ICS enable the functionality of numerous manufacturing processes, especially in the production of critical infrastructure components.
  • "NEMA and ISA realize the urgent need to promote the ISA/IEC 62443 series of standards," said Patrick Hughes, Senior Vice President, Technical & Industry Affairs, NEMA.
  • "This MOU will bring greater recognition of and reliance upon these critical OT cybersecurity standards that have been developed by ISA, the leading professional society for automation."
  • Developed by ISA and recognized by the International Electrotechnical Commission (IEC), the series of standards offers practicable guidance and resources to protect critical infrastructure and the supply chain.